<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Psychopharmacology (Berl)</journal-id><journal-id journal-id-type="iso-abbrev">Psychopharmacology (Berl.)</journal-id><journal-title-group><journal-title>Psychopharmacology</journal-title></journal-title-group><issn pub-type="ppub">0033-3158</issn><issn pub-type="epub">1432-2072</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26832339</article-id><article-id pub-id-type="pmc">4801988</article-id><article-id pub-id-type="publisher-id">4201</article-id><article-id pub-id-type="doi">10.1007/s00213-015-4201-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group></article-categories><title-group><article-title>The effect of a dopamine antagonist on conditioning of sexual arousal in women</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Brom</surname><given-names>Mirte</given-names></name><address><phone>+31 71 526 1545</phone><email>m.brom@lumc.nl</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff6"/></contrib><contrib contrib-type="author"><name><surname>Laan</surname><given-names>Ellen</given-names></name><address><email>e.t.laan@amc.uva.nl</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Everaerd</surname><given-names>Walter</given-names></name><address><email>W.T.A.M.Everaerd@uva.nl</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Spinhoven</surname><given-names>Philip</given-names></name><address><email>spinhoven@fsw.leidenuniv.nl</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Trimbos</surname><given-names>Baptist</given-names></name><address><email>j.b.m.z.trimbos@lumc.nl</email></address><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Both</surname><given-names>Stephanie</given-names></name><address><email>s.both@lumc.nl</email></address><xref ref-type="aff" rid="Aff6"/></contrib><aff id="Aff1"><label/>Institute of Psychology, Clinical Psychology Unit, Leiden University, Wassenaarseweg 52, Leiden, 2333 AK The Netherlands </aff><aff id="Aff2"><label/>Department of Sexology and Psychosomatic Obstetrics and Gynaecology, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands </aff><aff id="Aff3"><label/>Department Clinical Psychology, University of Amsterdam, Weesperplein 4, 1018 XA Amsterdam, The Netherlands </aff><aff id="Aff4"><label/>Department of Psychiatry, Leiden University Medical Centre, P.O. Box 9600, 2300 RC Leiden, The Netherlands </aff><aff id="Aff5"><label/>Department of Gynaecology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC Leiden, The Netherlands </aff><aff id="Aff6"><label/>Department of Psychosomatic Gynaecology &#x00026; Sexology, VRSP, Leiden University Medical Centre, Rijnsburgerweg 10, Zone PG4-Z, P.O. Box 9600, 2300 RC Leiden, The Netherlands </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>2</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="ppub"><year>2016</year></pub-date><volume>233</volume><fpage>1179</fpage><lpage>1189</lpage><history><date date-type="received"><day>6</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>21</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><sec><title>Rationale</title><p>Dopamine (DA) plays a key role in reward-seeking behaviours. Accumulating evidence from animal and human studies suggests that human sexual reward learning may also depend on DA transmission. However, research on the role of DA in human sexual reward learning is completely lacking.</p></sec><sec><title>Objectives</title><p>To investigate whether DA antagonism attenuates classical conditioning of sexual response in humans.</p></sec><sec><title>Methods</title><p>Healthy women were randomly allocated to one of two treatment conditions: haloperidol (<italic>n</italic>&#x02009;=&#x02009;29) or placebo (<italic>n</italic>&#x02009;=&#x02009;29). A differential conditioning paradigm was applied with genital vibrostimulation as unconditional stimulus (US) and neutral pictures as conditional stimuli (CSs). Genital arousal was assessed, and ratings of affective value and subjective sexual arousal were obtained.</p></sec><sec><title>Results</title><p>Haloperidol administration affected unconditional genital responding. However, no significant effects of medication were found for conditioned responding.</p></sec><sec><title>Conclusions</title><p>No firm conclusions can be drawn about whether female sexual reward learning implicates DA transmission since the results do not lend themselves to unambiguous interpretation.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Sexual conditioning</kwd><kwd>Dopamine antagonist</kwd><kwd>Sexual reward learning</kwd><kwd>Sexual response</kwd><kwd>Haloperidol</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id><institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution></institution-wrap></funding-source><award-id>n.a.</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag Berlin Heidelberg 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>The dopaminergic reward system has been implicated to be involved in the acquisition and expression of learned appetitive behaviours (Dominguez and Hull <xref ref-type="bibr" rid="CR25">2005</xref>; Fields et al. <xref ref-type="bibr" rid="CR29">2007</xref>; Richard et al. <xref ref-type="bibr" rid="CR58">2013</xref>; Schultz <xref ref-type="bibr" rid="CR62">2002</xref>), and abnormality in this system has been shown to play a role in the aetiology and pathophysiology of various disorders, including substance use disorders and (behavioural) addictions (De Jong et al. <xref ref-type="bibr" rid="CR20">2015</xref>; Dunlop and Nemeroff <xref ref-type="bibr" rid="CR27">2007</xref>; Root et al. <xref ref-type="bibr" rid="CR59">2015</xref>). Many theories of human sexual behaviour assume that sexual stimuli can obtain arousing properties through associative (classical/Pavlovian) learning processes (Brom et al. <xref ref-type="bibr" rid="CR12">2014a</xref>; Pfaus et al. <xref ref-type="bibr" rid="CR51">2001</xref>; Toates <xref ref-type="bibr" rid="CR70">2009</xref>). Therefore, the onset of disorders in sexual motivation such as female sexual interest/arousal disorder (Diagnostic and Statistical Manual of Mental Disorders [DSM-5] American Psychiatric Association 2013) or hypersexuality may be explained from a classical conditioning and incentive motivation perspective (Brom et al. <xref ref-type="bibr" rid="CR12">2014a</xref>; Laan and Both <xref ref-type="bibr" rid="CR40">2008</xref>; Singer and Toates <xref ref-type="bibr" rid="CR65">1987</xref>). However, despite the substantial amount of research that suggests that mesolimbic dopamine (DA) neurotransmission plays an important role in aversive learning (Zweifel et al. <xref ref-type="bibr" rid="CR76">2011</xref>), as well as reward learning (Berridge <xref ref-type="bibr" rid="CR3">2007</xref>; Berridge and Robinson <xref ref-type="bibr" rid="CR6">1998</xref>, <xref ref-type="bibr" rid="CR7">2003</xref>; Brom et al. <xref ref-type="bibr" rid="CR12">2014a</xref>; Di Chiara <xref ref-type="bibr" rid="CR24">1995</xref>; Kringelbach and Berridge <xref ref-type="bibr" rid="CR39">2009</xref>), to date, no human research has been conducted on the role of DA in human sexual reward learning, while facilitation as well as impairment thereof is relevant in the context of treatment of sexual motivation disorders.</p><p>Stimuli that can promote motivation are called incentive stimuli (Bindra <xref ref-type="bibr" rid="CR8">1974</xref>; Singer and Toates <xref ref-type="bibr" rid="CR65">1987</xref>). Their motivational valence can be unconditional or conditional as a result of associative leaning (Di Chiara <xref ref-type="bibr" rid="CR24">1995</xref>). A previously neutral stimulus (NS) that predicts reward (i.e. unconditional stimulus (US)) can acquire motivational properties, becoming an attractive and desirable incentive stimulus (i.e. conditional stimulus (CS)). As a result of repeated association of the NS with the US, the NS may eventually trigger similar responses as the US (i.e. the conditioned response (CR)) (Pavlov 1927). However, it is important to mention that the NS does not always have to trigger the exact same response as the US does (Fanselow et al. <xref ref-type="bibr" rid="CR28">1994</xref>), and therefore, the CR may not always equal the unconditioned response (UR). Subsequent repeated presentations of a CS without the US will result in a loss of conditioned responding (i.e. extinction), as the CS no longer predicts the appetitive US (Delamater <xref ref-type="bibr" rid="CR22">2004</xref>). Several studies have demonstrated conditioned sexual arousal responses in animals and humans (Both et al. <xref ref-type="bibr" rid="CR10">2011</xref>; Brom et al. <xref ref-type="bibr" rid="CR12">2014a</xref>, <xref ref-type="bibr" rid="CR13">b</xref>, <xref ref-type="bibr" rid="CR14">c</xref>; Pfaus et al. <xref ref-type="bibr" rid="CR51">2001</xref>).</p><p>Rewards like food, drugs and sex have the ability to stimulate mesolimbic DA neurons projecting from the ventral tegmental area (VTA) to the nucleus accumbens (NAc), and increased extracellular concentrations of mesolimbic DA are implicated in responding for conditioned reinforcers (Berridge <xref ref-type="bibr" rid="CR3">2007</xref>; Georgiadis and Kringelbach <xref ref-type="bibr" rid="CR32">2012</xref>; Pierce and Kumaresan <xref ref-type="bibr" rid="CR52">2006</xref>; Richard et al. <xref ref-type="bibr" rid="CR58">2013</xref>). A recent functional MRI (fMRI) study (Oei et al. <xref ref-type="bibr" rid="CR49">2012</xref>) provides compelling evidence for a mediating role of DA in processing of subconscious perceived sexual stimuli. In healthy young men, levodopa (a DA agonist) enhanced the activation in the NAc and dorsal anterior cingulate cortex in response to subliminal sexual stimuli, whereas haloperidol decreased activations in those areas. Both et al. (<xref ref-type="bibr" rid="CR9">2005</xref>) demonstrated a relation between dopaminergic activity and motor preparation in response to sexual stimuli. Moreover, substantial evidence suggests that mesolimbic DA plays a critical role in the incentive and acquisition aspect of reward (Berridge <xref ref-type="bibr" rid="CR3">2007</xref>; Schultz <xref ref-type="bibr" rid="CR62">2002</xref>; Wise <xref ref-type="bibr" rid="CR72">2002</xref>). The incentive salience theory describes mechanisms by which DA transmission in the NAc transforms the neural representations of conditioned stimuli, converting an event or environmental stimulus from a neutral representation into an attractive and &#x02018;wanted&#x02019; incentive (Berridge <xref ref-type="bibr" rid="CR3">2007</xref>; Flagel et al. <xref ref-type="bibr" rid="CR31">2010</xref>). Research has shown that DA agonists or DA uptake inhibitors, such as D-amphetamine or methylphenidate, increase conditioned responding in rats (Beninger and Phillips <xref ref-type="bibr" rid="CR2">1980</xref>; Cummins et al. <xref ref-type="bibr" rid="CR18">2014</xref>; Taylor and Robbins <xref ref-type="bibr" rid="CR68">1984</xref>) and humans (Kassubek et al. <xref ref-type="bibr" rid="CR37">2011</xref>), whereas DA antagonists decrease conditioned responding in rats (Banasikowski et al. <xref ref-type="bibr" rid="CR1">2010</xref>; Ranaldi and Beninger <xref ref-type="bibr" rid="CR56">1993</xref>; Wolterink et al. <xref ref-type="bibr" rid="CR74">1993</xref>). For instance, in rats, haloperidol selectively attenuates conditioned cue-induced sexual motivation (Coria-Avila et al. <xref ref-type="bibr" rid="CR17">2008</xref>; L&#x000f3;pez and Ettenberg <xref ref-type="bibr" rid="CR45">2002</xref>). In humans, dopaminergic influences on reward learning were observed in studies by Pessiglione et al. (<xref ref-type="bibr" rid="CR50">2006</xref>) and Pleger et al. (<xref ref-type="bibr" rid="CR54">2009</xref>), in which participants were administered a single dose of haloperidol or levodopa preceding an instrumental learning task and a reward decision-making task respectively. Haloperidol attenuated, and levodopa enhanced learning effects. However, in contrast, Pizzagalli et al. (<xref ref-type="bibr" rid="CR53">2008</xref>) and Santesso et al. (<xref ref-type="bibr" rid="CR61">2011</xref>) demonstrated that a single dose of the DA agonist pramipexole impaired the acquisition of reward-related behaviour in healthy participants. This blunted reward learning was explained by the assumption that low doses of pramipexole may influence reward via a paradoxical effect related to activation of the presynaptic DA autoreceptor, resulting in a blockade of phasic DA release and a blunted response to rewarding stimuli (Riba et al. <xref ref-type="bibr" rid="CR57">2008</xref>). As the mixed results make clear, the role of DA signalling in incentive learning in humans remains largely unknown. Therefore, in the present study, making use of a double-blind, placebo-controlled design, it was investigated whether DA antagonism attenuates classical conditioning of sexual response in women. It was expected that administration of the DA antagonist haloperidol would decrease the magnitude of the conditioned sexual response.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Method</title><sec id="Sec3"><title>Participants</title><p>A total of 58 healthy sexually active women from the general population were recruited by means of advertisements and were randomly allocated to two treatment conditions: placebo <italic>n</italic>&#x02009;=&#x02009;29 and haloperidol <italic>n</italic>&#x02009;=&#x02009;29. The inclusion criteria were age between 18 and 45&#x000a0;years and a heterosexual orientation; no pregnancy or breastfeeding; no current (or history of) sexual complaints as determined by the Female Sexual Function Index (FSFI; Rosen et al. <xref ref-type="bibr" rid="CR60">2000</xref>; Ter Kuile et al. <xref ref-type="bibr" rid="CR69">2006</xref>) or psychiatric problems as determined by the MINI International Neuropsychiatric Interview (MINI; Sheehan et al. <xref ref-type="bibr" rid="CR63">1998</xref>); no history of sexual abuse; no medical illness (or medical history) indicating a risk in using haloperidol (e.g. cardiac illness, depression, thyroid disorders, glaucoma); no use of medication affecting sexual response and no current or recent use (&#x0003c;12&#x000a0;weeks before participation) of psycho-pharmacological medication, psychotropic drugs or medication that might interfere with haloperidol (e.g. cannabis or cocaine). Participants were paid &#x020ac;50 for their participation, and written informed consent was obtained from all participants. The study was approved by the Medical Ethics Committee and carried out according to the standards of the Declaration of Helsinki (Declaration of Helsinki 2000).</p></sec><sec id="Sec4"><title>Medication</title><p>Participants received a single dose of haloperidol (3&#x000a0;mg, the mean time of maximal plasma levels (<italic>T</italic><sub>max</sub>)&#x02009;=&#x02009;3&#x02013;6&#x000a0;h, half-time&#x02009;=&#x02009;14&#x02013;36&#x000a0;h; Liem-Moolenaar et al. <xref ref-type="bibr" rid="CR43">2010</xref>) or placebo (microcristalline cellulose), hidden in identical gelatine capsules to ensure that both participants and experimenters could not identify the drugs. Following dosing, participants rested for 3&#x000a0;h to allow drug absorption. This timing was based upon a studies in healthy volunteers that showed 60&#x02013;70&#x000a0;% D2 receptor occupancy and maximal plasma concentrations 3&#x000a0;h after haloperidol administration (Darby et al. <xref ref-type="bibr" rid="CR19">1995</xref>; Nordstrom et al. <xref ref-type="bibr" rid="CR47">1992</xref>) and on research that showed haloperidol effects 1&#x000a0;h after dosing on cognitive tests making use of a reliable central nervous system (CNS) measurement battery (Liem-Moolenaar et al. <xref ref-type="bibr" rid="CR43">2010</xref>). Moreover, previous studies from our lab (Oei et al. <xref ref-type="bibr" rid="CR49">2012</xref>) demonstrated decreased activations in brain reward structures 4&#x000a0;h after oral ingestion of 3&#x000a0;mg haloperidol.</p></sec><sec id="Sec5"><title>Conditioning procedure</title><p>The experimental design involved differential conditioning with one stimulus (the CS+) being followed by genital vibrostimulation (US) during the acquisition phase, whereas the other stimulus (CS&#x02212;) was never followed by genital vibrostimulation. For a schematic overview of the procedure, see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. In the preconditioning phase, participants saw four non-reinforced presentations of the CS+ and four presentations of the CS&#x02212;, for 11&#x000a0;s each. Subsequently, in the acquisition phase, the CS+ and CS&#x02212; were presented eight times each, and after 10&#x000a0;s, the CS+ was always followed by the US for 2&#x000a0;s. In the extinction phase, the CS+ and CS&#x02212; were presented six times each, and now, the CS+ was no longer followed by the US. All phases were presented without interruption. There were two random CS orders for each phase (that was counterbalanced across participants), with the restriction of only two successive presentations of each CS. During the whole procedure, inter-trial intervals (ITIs) were 20, 25 or 30&#x000a0;s. The order of the length of the ITI was random, with the restriction of only two similar successive lengths.<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic representation of the conditioning procedure and extinction phase, with on the <italic>right</italic> the used stimuli that served as CSs</p></caption><graphic xlink:href="213_2015_4201_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec6"><title>Stimulus materials</title><p>Two similar neutral pictures of pictorial male faces (Both et al. <xref ref-type="bibr" rid="CR10">2011</xref>; Brom et al. <xref ref-type="bibr" rid="CR13">2014b</xref>) served as CSs. The CSs were shown in the middle of a computer monitor, approximately 1.5&#x000a0;m in front of the participant. The size of the presented pictures was 14&#x02009;&#x000d7;&#x02009;21&#x000a0;cm. Assignment of the pictures as CS+ and CS&#x02212; was counterbalanced across participants and conditions. A computer program timed the administration of the CS and US stimuli.</p></sec><sec id="Sec7"><title>Genital vibrostimulation (US)</title><p>A small hands-off vibrator (2-cm diameter) (Both et al. <xref ref-type="bibr" rid="CR11">2008</xref>, <xref ref-type="bibr" rid="CR10">2011</xref>; Brom et al. <xref ref-type="bibr" rid="CR13">2014b</xref>) was placed on the clitoris using a lycra panties. All participants were instructed to position the vibrator as <italic>most sexually stimulating</italic>.</p></sec><sec id="Sec8"><title>Genital arousal</title><p>Vaginal photoplethysmography assessed vaginal pulse amplitude (VPA) (Laan and Everaerd <xref ref-type="bibr" rid="CR41">1995</xref>; Laan et al. <xref ref-type="bibr" rid="CR42">1995</xref>). VPA is a reliable measure specific to sexual arousal (Laan et al. <xref ref-type="bibr" rid="CR42">1995</xref>; Suschinsky et al. <xref ref-type="bibr" rid="CR67">2009</xref>). The photoplethysmograph is a menstrual tampon-sized device containing an orange-red light source and a photocell. The light source illuminates the capillary bed of the vaginal wall and the blood circulation within it. Depth of the probe and orientation of the light emitting diode were controlled by a device (a 6&#x02009;&#x000d7;&#x02009;2-cm plate) attached to the cable within 5&#x000a0;cm of the light sensor. The photoplethysmograph was disinfected at the medical centre by means of a plasma sterilization procedure between uses. Plasma sterilization is a highly effective method for the complete removal of all organic (and certain inorganic) material. Genital response was measured continuously during resting baseline, preconditioning, acquisition and extinction phases.</p></sec><sec id="Sec9"><title>Subjective ratings</title><p>Ratings of affective value and sexual arousal were collected during the preconditioning and extinction phases. Participants were first asked to rate, after each CS presentation, the affective value of the CSs by answering the question &#x02018;<italic>What kind of feeling does this picture evoke in you</italic>?&#x02019; The question could be answered on a 7-point Likert scale on a keyboard that varied from <italic>very negative</italic> to <italic>very positive</italic>. Then, subjective sexual arousal was rated by answering the question &#x02018;<italic>How sexually arousing is this picture to you</italic>?&#x02019; The question could be answered on a 7-point scale that varied from <italic>not sexually arousing at all</italic> to <italic>very sexually arousing</italic>. The questions were presented at the monitor 1&#x000a0;s following the end of picture presentation.</p></sec><sec id="Sec10"><title>The Female Sexual Function Index</title><p>Women&#x02019;s sexual functioning was assessed by the FSFI (Rosen et al. <xref ref-type="bibr" rid="CR60">2000</xref>; Ter Kuile et al. <xref ref-type="bibr" rid="CR69">2006</xref>), consisting of six subscales: desire (two items; range 1&#x02013;5), arousal (four items; range 0&#x02013;5), lubrication (four items; range 0&#x02013;5), orgasm (three items; range 0&#x02013;5), satisfaction (three items; range 0&#x02013;5) and pain (three items; range 0&#x02013;5). A higher score indicates better sexual functioning. The FSFI has good internal reliability and is able to differentiate between clinical samples and functional controls (Rosen et al. <xref ref-type="bibr" rid="CR60">2000</xref>; Ter Kuile et al. <xref ref-type="bibr" rid="CR69">2006</xref>).</p></sec><sec id="Sec11"><title>Procedure</title><p>A female who was a trained experimenter tested each participant individually. Women were not tested during menstruation. Before entering the experimental session, participants were instructed about the genital device and vibrostimulation and informed consent was obtained. Participants received a capsule (placebo or haloperidol) 3&#x000a0;h before the experimental conditioning procedure to ensure the occurrence of peak plasma concentrations of the drugs during the experiment (Darby et al. <xref ref-type="bibr" rid="CR19">1995</xref>; Liem-Moolenaar et al. <xref ref-type="bibr" rid="CR43">2010</xref>; Nordstrom et al. <xref ref-type="bibr" rid="CR47">1992</xref>). After ingestion of the capsule, participants filled out questionnaires (e.g. FSFI). They were allowed to read during the waiting period. Exactly 3&#x000a0;h after ingesting the capsule, the experimental procedure started. Participants privately inserted the vaginal device and placed the vibrator. Further instructions were given through instructions on screen. Three presentations of vibrostimulation of 2&#x000a0;s each allowed the participant to position the vibrator in the way it was <italic>most sexually arousing</italic>. It was emphasized that after final placement, the position of the vibrator should not be changed during the experiment. A 5-min resting period followed, during which a neutral film was played and baseline measurements of genital response were collected during the last 2&#x000a0;min. Subsequently, the conditioning procedure followed. After the experiment finished, participants themselves removed the genital devices privately. Next, a debriefing interview was administered in which participants were asked about their sentiments with regard to the experimental procedure, the use of the genital device and their evaluation of the genital vibrostimulation. Finally, participants were thanked and paid for their participation and advised to refrain from alcohol and drug use the next 24&#x000a0;h.</p></sec><sec id="Sec12"><title>Data reduction, scoring and analysis</title><p>A software program (VSRRP98) was used to analyze the genital data. After artefact removal, mean VPA level during the 2-min resting baseline period was calculated. Genital responses to the CSs were scored in three latency windows: during 4&#x02013;8, 9&#x02013;12 and 13&#x02013;16&#x000a0;s following CS onset, respectively first interval response (FIR), second interval response (SIR) and third interval response (TIR). These time intervals are based on previous data (Both et al. <xref ref-type="bibr" rid="CR10">2011</xref>; Brom et al. <xref ref-type="bibr" rid="CR13">2014b</xref>) showing that vaginal blood engorgement is a relatively slow physiological response. For FIR, SIR and TIR, change scores were calculated for each CS presentation by subtracting mean genital resting baseline from genital response following CS presentation. For genital responses and subjective ratings, effects were tested with repeated measures univariate analysis of variance procedures (general linear model in SPSS), with stimulus and trial as within-subject factors and condition as between-subject factor. The Greenhouse&#x02013;Geisser correction was applied to adjust for violation of the sphericity assumption in testing repeated measures effects. The preconditioning, acquisition and extinction phases were analyzed separately. Effect sizes are reported as proportion of partial variance (<italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>) (Cohen <xref ref-type="bibr" rid="CR16">1988</xref>). In addition, the strength of the unconditioned and conditioned genital response was determined. The magnitude of the UR was determined by calculating the percentage of preconditioning VPA score (mean VPA in response to the CS+ plus vibration during the acquisition phase&#x02009;/&#x02009;mean VPA in response to the CS+ during the preconditioning phase&#x02009;&#x000d7;&#x02009;100). The magnitude of the CR was determined by calculating the percentage of the mean VPA in response to vibration (VPA in response to the CS+ during the first extinction trial&#x02009;/&#x02009;mean VPA in response to the CS+ plus vibration during the acquisition phase&#x02009;&#x000d7;&#x02009;100).</p></sec></sec><sec id="Sec13" sec-type="results"><title>Results</title><p>The participants in the two conditions appeared to differ in age and in prior experience with genital vibrostimulation, see Table <xref rid="Tab1" ref-type="table">1</xref><italic>Participant characteristics</italic>. Genital data from one participant (from the haloperidol condition) were discarded as outlier since measures from this participant were under 3 SD from the mean (although inclusion of this participant did not change results). There was no relation between the medication the participants had received and the percentage that correctly guessed what they had received (Pearson chi-squared&#x02009;=&#x02009;2.75, <italic>p</italic>&#x02009;=&#x02009;0.25), suggesting that blinding was successful. Most participants reported no side effects (<italic>n</italic>&#x02009;=&#x02009;37). Among the 21 participants who did report side effects, the most commonly reported ones were fatigue, sleepiness and dizziness. Participants in the haloperidol condition reported more side effects as compared to participants in the placebo condition (Fisher&#x02019;s exact test&#x02009;=&#x02009;6.05, <italic>p</italic>&#x02009;=&#x02009;0.03). The most frequent reported side effect was dizziness.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Participant characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="2"/><th colspan="2">Placebo (<italic>n</italic>&#x02009;=&#x02009;29)</th><th colspan="2">Haloperidol (<italic>n</italic>&#x02009;=&#x02009;29)</th><th/></tr><tr><th>M</th><th>SD</th><th>M</th><th>SD</th><th>
<italic>p</italic>
</th></tr></thead><tbody><tr><td colspan="2">Age (years)</td><td>22.24</td><td>3.14</td><td>20.31</td><td>1.71</td><td>&#x0003c;0.01*</td></tr><tr><td colspan="2">Sexual functioning (FSFI score)</td><td>28.63</td><td>5.97</td><td>28.81</td><td>5.63</td><td>0.90</td></tr><tr><td colspan="2">Prior experience vibrostimulation</td><td>3.00</td><td>1.28</td><td>2.24</td><td>1.12</td><td>0.02*</td></tr><tr><td colspan="2">Pleasantness US</td><td>2.24</td><td>0.64</td><td>2.28</td><td>0.65</td><td>0.84</td></tr><tr><td colspan="2">US perceived as sexually arousing</td><td>2.62</td><td>0.78</td><td>2.48</td><td>0.63</td><td>0.46</td></tr><tr><td colspan="2">Declared sexual arousal</td><td>2.03</td><td>0.73</td><td>2.14</td><td>0.69</td><td>0.58</td></tr><tr><td colspan="2"/><td>Frequency</td><td/><td>Frequency</td><td/><td/></tr><tr><td rowspan="2">Use of contraceptives</td><td>No use or non-hormonal</td><td>5</td><td/><td>3</td><td/><td rowspan="2">0.72</td></tr><tr><td>Hormonal</td><td>24</td><td/><td>26</td><td/></tr></tbody></table><table-wrap-foot><p>Descriptive subject variables for each condition. Women&#x02019;s sexual functioning was assessed by the Female Sexual Function Index (FSFI; Rosen et al. <xref ref-type="bibr" rid="CR60">2000</xref>; Ter Kuile et al. <xref ref-type="bibr" rid="CR69">2006</xref>). Questions from debriefing, scales: prior experience vibrostimulation 1 (never)&#x02013;5 (very often); pleasantness US 1 (not pleasant at all)&#x02013;5 (very pleasant); US perceived as sexually arousing 1 (not sexually arousing at all)&#x02013;5 (very sexually arousing); declared sexual arousal 1 (not sexually aroused at all)&#x02013;5 (very sexually aroused)</p><p>*<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05</p></table-wrap-foot></table-wrap></p><sec id="Sec14"><title>Genital sexual arousal</title><sec id="Sec15"><title>Preconditioning phase</title><p>Analyses were conducted to verify equal levels of VPA in response to the CS+ and CS&#x02212; during the preconditioning phase. For all latency windows (FIR, SIR and TIR), no difference in VPA following presentation of the CS+ and CS&#x02212; was found, all <italic>p</italic>s&#x02009;&#x0003e;&#x02009;0.23. On TIR, a significant stimulus &#x000d7; condition interaction effect was found, <italic>F</italic>(1, 55)&#x02009;=&#x02009;6.74, <italic>p</italic>&#x02009;=&#x02009;0.01, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.11. As can be seen in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>, participants in the haloperidol condition demonstrated higher VPA responses towards the CS&#x02212;, whereas women in the placebo condition had higher VPA in response to the CS+ in the preconditioning phase.<fig id="Fig2"><label>Fig. 2</label><caption><p>Mean vaginal pulse amplitude (VPA) change scores (with standard error bars) for the conditions placebo and haloperidol, during the third interval response window (TIR) following CS+ and CS&#x02212; during the preconditioning phase, acquisition phase and extinction phase. Note that during the acquisition phase, the response represents responding to the CS+ plus the US (given that animal studies on conditioned sexual response have revealed interactions between sex steroids and DA in the control of sexual behaviour (see Brom et al. <xref ref-type="bibr" rid="CR12">2014a</xref>) and have revealed influences of estrous cycle phase on conditioning and extinction (Milad et al. <xref ref-type="bibr" rid="CR46">2006</xref>); additional analyses were conducted, controlled for women during their early follicular phase (i.e. early cycle) and during the late follicular phase (i.e. midcycle). However, those analyses revealed no additional differences between conditions</p></caption><graphic xlink:href="213_2015_4201_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec16"><title>Acquisition phase</title><p>VPA in response to the vibrostimulation during the acquisition phase was determined in order to verify whether the vibrostimulation served as a sexually arousing US. Genital responses in the second and third latency windows (SIR, TIR) were considered as unconditioned responses. Figure <xref rid="Fig2" ref-type="fig">2</xref> summarizes VPA TIR to CS+ and CS&#x02212; across trials for both conditions separately. In line with previous studies (Both et al. <xref ref-type="bibr" rid="CR11">2008</xref>, <xref ref-type="bibr" rid="CR10">2011</xref>; Brom et al. <xref ref-type="bibr" rid="CR13">2014b</xref>), the 2 (stimulus) &#x000d7; 8 (trial) &#x000d7; 2 (condition) mixed factors ANOVA of VPA revealed only a significant main effect of stimulus on TIR, FIR <italic>p</italic>&#x02009;=&#x02009;0.28, SIR, <italic>p</italic>&#x02009;=&#x02009;0.11, TIR, <italic>F</italic>(1, 54)&#x02009;=&#x02009;5.65, <italic>p</italic>&#x02009;=&#x02009;0.02, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.10, meaning the CS+ plus vibrostimulation elicited higher levels of VPA. On FIR and SIR, there were no significant stimulus &#x000d7; condition interaction effects, FIR <italic>p</italic>&#x02009;=&#x02009;0.51, SIR <italic>p</italic>&#x02009;=&#x02009;0.38, or stimulus &#x000d7; trial &#x000d7; condition interaction effects, FIR <italic>p</italic>&#x02009;=&#x02009;0.86; SIR <italic>p</italic>&#x02009;=&#x02009;0.29. On TIR, there was a trend for a stimulus &#x000d7; condition interaction, <italic>F</italic>(1, 54)&#x02009;=&#x02009;3.16, <italic>p</italic>&#x02009;=&#x02009;0.08, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.06, and for a stimulus &#x000d7; trial &#x000d7; condition interaction, <italic>F</italic>(5, 250)&#x02009;=&#x02009;2.19, <italic>p</italic>&#x02009;=&#x02009;0.06, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.04. Inspection of Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> suggests that the placebo condition demonstrated greater differential responding in the second half of the acquisition phase compared to the haloperidol condition. Additional analysis of the first half of the acquisition trials (trials 1&#x02013;4 of acquisition phase) yielded a significant stimulus &#x000d7; trial &#x000d7; condition interaction effect on TIR <italic>F</italic>(3, 143)&#x02009;=&#x02009;3.87, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.02, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.07, and analysis of the second half of the acquisition phase (trials 5&#x02013;8) yielded a significant stimulus &#x000d7; condition interaction on TIR, <italic>F</italic>(1, 55)&#x02009;=&#x02009;4.65, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.04, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.08. Because conditions differed in age, with the placebo condition being significantly older than the haloperidol condition (see Table <xref rid="Tab1" ref-type="table">1</xref>), and in prior experience with vibrostimulation and in the difference in VPA towards CS+/CS&#x02212; during the preconditioning phase, additional analyses were conducted with those variables as covariates. On TIR, again a significant main effect of stimulus was seen, <italic>F</italic>(1, 51)&#x02009;=&#x02009;5.23, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.03, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.10, and a significant stimulus &#x000d7; condition interaction effect, <italic>F</italic>(1, 51)&#x02009;=&#x02009;6.32, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.02, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.11. Also, a trend for a stimulus &#x000d7; age interaction, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.09, was seen. Concluding, the vibrostimulation resulted in a genital arousal response in both conditions, and results from the additional analysis showed that administration of a DA antagonist decreased the magnitude of differential responding towards the CS+ plus vibrostimulation and CS&#x02212; in the second half of the acquisition phase.</p></sec><sec id="Sec17"><title>Extinction phase</title><p>Analysis of the first extinction trial revealed no conditioned responding, FIR <italic>p</italic>&#x02009;=&#x02009;0.47, SIR <italic>p</italic>&#x02009;=&#x02009;0.32, TIR <italic>p</italic>&#x02009;=&#x02009;0.64, with no differences therein between the conditions, FIR <italic>p</italic>&#x02009;=&#x02009;0.93; SIR <italic>p</italic>&#x02009;=&#x02009;0.99; TIR <italic>p</italic>&#x02009;=&#x02009;0.65. The 2 (stimulus) &#x000d7; 6 (trial) &#x000d7; 2 (condition) mixed factors ANOVA of all extinction trials also did not reveal conditioned responding, all <italic>p</italic>s&#x02009;&#x0003e;&#x02009;0.19, and no stimulus &#x000d7; trial &#x000d7; condition interaction effect, all <italic>p</italic>s&#x02009;&#x0003e;&#x02009;0.53. However, a less stringent method, namely analysis of only the response towards the CS+ on the last preconditioning trial and on the first extinction trial, revealed a difference in conditioned responding between the placebo and haloperidol condition, as reflected by a significant trial &#x000d7; condition interaction effect on SIR, <italic>F</italic>(1, 54)&#x02009;=&#x02009;4.89, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.03, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.08, and a trend for a trial &#x000d7; condition interaction on TIR <italic>F</italic>(1, 54)&#x02009;=&#x02009;3.81, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.06, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.07. Additional analyses were conducted with the variables age, prior experience vibrostimulation and difference in VPA towards CS+/CS&#x02212; during the preconditioning phase as covariates. Analysis of the first extinction trial again revealed no conditioned responding on FIR and SIR and no differences therein between conditions, all <italic>p</italic>s&#x02009;&#x0003e;&#x02009;0.28. On TIR, a trend of stimulus was seen, <italic>F</italic>(1, 49)&#x02009;=&#x02009;3.51, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.07, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.07, but a non-significant stimulus &#x000d7; condition interaction effect, <italic>p</italic>&#x02009;=&#x02009;0.11. Additionally, the 2 (stimulus) &#x000d7; 6 (trial) &#x000d7; 2 (condition) mixed factors ANOVA of all extinction trials now revealed conditioned responding on SIR, <italic>F</italic>(1, 49)&#x02009;=&#x02009;5.25, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.03, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.10, but no differences therein between conditions, <italic>p</italic>&#x02009;=&#x02009;0.23. On TIR, no conditioned responding was seen, again with no differences therein between conditions, all <italic>p</italic>s&#x02009;&#x0003e;&#x02009;0.10. The analysis of only responses towards the CS+ on the last preconditioning trial and on the first extinction trial revealed no difference in conditioned responding between the conditions, all <italic>p</italic>s&#x02009;&#x0003e;&#x02009;0.10. To conclude, administration of haloperidol did not decrease the magnitude of the conditioned sexual response compared to the placebo condition.</p></sec></sec><sec id="Sec18"><title>Subjective measures</title><sec id="Sec19"><title>Preconditioning phase</title><p>The 2 (stimulus) &#x000d7; 4 (trial) &#x000d7; 2 (condition) mixed factors ANOVA to verify equal levels of responding to the CSs revealed no difference in responding following presentation of the CS+ and CS&#x02212; on affective value and subjective sexual arousal, or between conditions, all <italic>p</italic>s&#x02009;&#x0003e;&#x02009;0.25.</p></sec></sec><sec id="Sec20"><title>Extinction phase</title><sec id="Sec21"><title>Subjective affect</title><p>As can be seen in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>, contrary to the expectations, for subjective affect, there was no robust increase of differential responding towards CS+ and CS&#x02212; after the acquisition phase. Analysis of the first extinction trial revealed no significant stimulus &#x000d7; condition interaction effect, <italic>p</italic>&#x02009;=&#x02009;0.98, and no main effect of stimulus, <italic>p</italic>&#x02009;=&#x02009;0.14. Analysis of ratings of affective value during the preconditioning phase (mean trials 1&#x02013;4) and the first extinction trial revealed no stimulus &#x000d7; condition interaction effect, <italic>p</italic>&#x02009;=&#x02009;0.83, nor a stimulus &#x000d7; trial &#x000d7; condition interaction effect, <italic>p</italic>&#x02009;=&#x02009;0.70. The 2 (stimulus) &#x000d7; 6 (trial) &#x000d7; 2 (condition) mixed factors ANOVA of all extinction trials revealed no differences between conditions, as reflected by non-significant stimulus &#x000d7; condition and stimulus &#x000d7; trial &#x000d7; condition interaction effects, all <italic>p</italic>s&#x02009;&#x0003e;&#x02009;0.64. A trend of stimulus was seen, <italic>F</italic>(1, 48)&#x02009;=&#x02009;2.97, <italic>p</italic>&#x02009;=&#x02009;0.09, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.06. Analysis with age and prior experience vibrostimulation as covariates showed a similar pattern of results.<fig id="Fig3"><label>Fig. 3</label><caption><p>Subjective affect ratings (with standard error bars) following the CS+ and CS&#x02212; during the preconditioning phase and extinction phase in the two conditions placebo (<italic>left</italic>) and haloperidol (<italic>right</italic>)</p></caption><graphic xlink:href="213_2015_4201_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec22"><title>Subjective sexual arousal</title><p>Figure <xref rid="Fig4" ref-type="fig">4</xref> shows increased ratings of subjective sexual arousal towards the CS+ on the first trials of the extinction phase, indicating conditioned response, in both conditions. Analysis of ratings of subjective sexual arousal during the preconditioning phase (mean trials 1&#x02013;4) and the first extinction trial revealed no significant stimulus &#x000d7; condition interaction effect, <italic>p</italic>&#x02009;=&#x02009;0.48, or stimulus &#x000d7; trial &#x000d7; condition interaction effect, <italic>p</italic>&#x02009;=&#x02009;0.91. However, a significant main effect of stimulus was seen, <italic>F</italic>(1, 54)&#x02009;=&#x02009;9.71, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.15, indicating conditioned responding. Analysis of the first extinction trial yielded no significant stimulus &#x000d7; condition interaction, <italic>p</italic>&#x02009;=&#x02009;0.76. Again, a main effect of stimulus was found, <italic>F</italic>(1, 55)&#x02009;=&#x02009;7.06, <italic>p</italic>&#x02009;=&#x02009;0.01, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.11. The 2 (stimulus) &#x000d7; 6 (trial) &#x000d7; 2 (condition) mixed factors ANOVA of all extinction trials revealed no significant interaction effects of stimulus &#x000d7; condition or stimulus &#x000d7; trial &#x000d7; condition, both <italic>p</italic>s&#x02009;&#x0003e;&#x02009;0.39. However, there was a significant stimulus &#x000d7; trial interaction effect, <italic>F</italic>(3, 148)&#x02009;=&#x02009;2.76, <italic>p</italic>&#x02009;=&#x02009;0.04, <italic>&#x003b7;</italic><sub arrange="stack"><italic>p</italic></sub><sup arrange="stack">2</sup>=.06, indicating extinction of conditioned responding. Analyses with age and prior experience vibrostimulation as covariates showed a similar pattern as reported above. To conclude, the modulation of dopaminergic tone with haloperidol did not decrease the magnitude of conditioned subjective affect or sexual arousal as compared to the placebo condition.<fig id="Fig4"><label>Fig. 4</label><caption><p>Ratings (with standard error bars) of subjective sexual arousal following the CS+ and CS&#x02212; during the preconditioning phase and extinction phase in the two conditions placebo (<italic>left</italic>) and haloperidol (<italic>right</italic>)</p></caption><graphic xlink:href="213_2015_4201_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec23"><title>Magnitude of the conditioned genital response</title><p>Compared to the unconditioned genital response, the magnitude of the CR during the first extinction trial was 116.8 and 98&#x000a0;%, respectively, for VPA SIR and TIR for the placebo condition. For the DA condition, this was 72.2 and 51.1&#x000a0;%. No significant differences were seen between conditions therein, all <italic>p</italic>s&#x02009;&#x0003e;&#x02009;0.28.</p></sec></sec><sec id="Sec24" sec-type="conclusion"><title>Conclusions</title><p>To investigate whether DA signalling is a prerequisite in sexual reward learning in humans, dopaminergic tone in healthy women during a sexual conditioning paradigm was manipulated. First, results demonstrated that DA receptor antagonism reduced sexual stimulation-induced genital sexual arousal, emphasizing the importance of DA in unconditional responding to sexual stimulation. However, contrary to the expectations, no differences in conditioned genital responding were seen between the placebo and haloperidol condition after the acquisition phase. Both conditions demonstrated only slight conditioned genital response, but only after correcting for age, prior experience with vibrostimulation and for the difference in genital response towards the CSs during the preconditioning phase. Regarding ratings of affective value, contrary to the expectations, no differential responding towards CS+ and CS&#x02212; after the acquisition phase could be detected, and contrary to the hypothesis, no differences therein were seen between conditions. For ratings of subjective sexual arousal, women in both the placebo and haloperidol condition demonstrated increased ratings towards the CS+ on the first trials of the extinction phase. However, the conditions did not differ in this conditioned response.</p><p>Results from the present study suggest that DA availability indeed contributes to unconditioned behavioural responses to sexual rewarding stimuli. This is in accordance with previous work that showed that DA systems are involved in (sexual) reward signalling (Both et al. <xref ref-type="bibr" rid="CR9">2005</xref>; Brom et al. <xref ref-type="bibr" rid="CR12">2014a</xref>; Georgiadis and Kringelbach <xref ref-type="bibr" rid="CR32">2012</xref>; Oei et al. <xref ref-type="bibr" rid="CR49">2012</xref>). Quite intriguing is the finding that DA downregulation did not seem to affect subsequent conditioned genital response and conditioned subjective sexual arousal. However, it is important to keep in mind that only very weak conditioned genital responding was seen, making it not straightforward to conclude that administration of the DA receptor antagonist haloperidol did not influence conditioned sexual response in healthy women. This is also evidenced by the data on the magnitude of the genital conditioned response. This finding of only mild conditioned genital response is surprising, especially when considering that similar parameters to those of previous research were used, when evidence for genital conditioning effects were found (Both et al. <xref ref-type="bibr" rid="CR11">2008</xref>, <xref ref-type="bibr" rid="CR10">2011</xref>; Brom et al. <xref ref-type="bibr" rid="CR13">2014b</xref>, <xref ref-type="bibr" rid="CR14">c</xref>). Compared to this previous research, in the present study, women in both conditions rated the US as less pleasant and less sexually arousing. Although we do not have a clear explanation for why women experienced the US as less sexually arousing and why no conditioned genital response could be detected in the placebo condition, we should mention that sexually conditioned genital responses have generally been found to be small (Brom et al. <xref ref-type="bibr" rid="CR12">2014a</xref>; Hoffmann et al. <xref ref-type="bibr" rid="CR36">2004</xref>; O&#x02019;Donohue and Plaud <xref ref-type="bibr" rid="CR48">1994</xref>). Of importance, women in the placebo condition had significantly more experience with genital vibrostimulation. Since the attribution of incentive salience is the product of previous experience (i.e. learned associations; habituation) interacting with someone&#x02019;s genetic propensity and neurobiological state (Flagel et al. <xref ref-type="bibr" rid="CR30">2011</xref>), it could be that the US was less effective and rewarding for participants in the placebo condition. The above makes clear that further replications of the sexual conditioning results in independent samples are highly important.</p><p>Although administration of haloperidol resulted in an attenuated unconditioned genital response, this did not seem to affect the perceived pleasantness or sexual arousability of the US or the magnitude of conditioned subjective sexual arousal. Moreover, in an earlier study on sexual response (Both et al. <xref ref-type="bibr" rid="CR9">2005</xref>), levodopa seemed only to increase T reflex magnitude in response to sexual stimulation in men (and not in women), whereas genital and subjective sexual arousal were not affected by levodopa. This suggests that subjectively reported feelings may not be affected by DA signalling. The conscious awareness of a motivational state may be dissociable from the underlying motivational processes (Berridge <xref ref-type="bibr" rid="CR4">1996</xref>; Berridge and Kringelbach <xref ref-type="bibr" rid="CR5">2008</xref>). Moreover, the fact that sexual response systems can diverge has long been recognized, especially in women (Chivers et al. <xref ref-type="bibr" rid="CR15">2010</xref>; Laan and Everaerd <xref ref-type="bibr" rid="CR41">1995</xref>; Laan et al. <xref ref-type="bibr" rid="CR42">1995</xref>). Women can show increases in VPA, while no increases in self-reported sexual arousal are observed, or vice versa.</p><p>Several limitations of the current study should be noted. Although we may assume that the administration of 3&#x000a0;mg haloperidol 3&#x000a0;h before the start of the experimental procedure indeed effectively inhibited dopaminergic tone (Darby et al. <xref ref-type="bibr" rid="CR19">1995</xref>; Liem-Moolenaar et al. <xref ref-type="bibr" rid="CR43">2010</xref>; Nordstrom et al. <xref ref-type="bibr" rid="CR47">1992</xref>; Oei et al. <xref ref-type="bibr" rid="CR49">2012</xref>), also reflected by the difference in reported adverse effects between the haloperidol and placebo conditions, future studies should incorporate additional sensitive measurements of drug-induced CNS effects (Liem-Moolenaar et al. <xref ref-type="bibr" rid="CR43">2010</xref>), to assure testing during maximal plasma concentrations. Moreover, since haloperidol exhibits polypharmacology (i.e. it may affect multiple receptor proteins in the nervous system; Seeman <xref ref-type="bibr" rid="CR64">2002</xref>; Videbaeck et al. <xref ref-type="bibr" rid="CR71">2001</xref>), future studies on sexual reward learning in humans should preferably make use of positron emission tomography and selective ligands in order to be able to attribute its effects to action on D2 receptors. Second, the present study sample exclusively comprised women. Results from a fMRI study by Klucken et al. (<xref ref-type="bibr" rid="CR38">2009</xref>) on sexual conditioning revealed stronger conditioned activation in the amygdala, thalamus and occipital cortex in men compared to women. The researchers considered these results to be in line with other findings (Guti&#x000e9;rrez and Domjan <xref ref-type="bibr" rid="CR33">1997</xref>; Pfaus et al. <xref ref-type="bibr" rid="CR51">2001</xref>). Research has demonstrated that gender differences in the number of DA neurons are influenced by several factors, including sex chromosome complement (Lombardo et al. <xref ref-type="bibr" rid="CR44">2012</xref>), the presence of the SRY gene (Dewing et al. <xref ref-type="bibr" rid="CR23">2006</xref>) and gonadal hormones. Moreover, it is suggested that testosterone regulates incentive sensitivity through interactions with mesolimbic DA pathways (Hermans et al. <xref ref-type="bibr" rid="CR34">2010</xref>; Wood <xref ref-type="bibr" rid="CR75">2008</xref>). Additionally, previous studies have reported conflicting results about the effects of DA on female sexual motivation in animals and humans (Both et al. <xref ref-type="bibr" rid="CR9">2005</xref>). This and present findings make clear that future research on the role of DA in sexual learning in both sexes in humans is warranted, as these findings may help in the understanding of the biological mechanisms underpinning addictive behaviours and how these may affect vulnerability to drug abuse or the development of sexual dysfunctions in men and women. In the present study, almost all participants used hormonal contraception. It is known that hormonal contraception may have an influence on the neurochemical regulation of dopaminergic midbrain areas involved in neurobiological processes, herewith affecting reward learning (Brom et al. <xref ref-type="bibr" rid="CR12">2014a</xref>; Pletzer and Kerschbaum <xref ref-type="bibr" rid="CR55">2014</xref>; Sotomayor-Zarate et al. <xref ref-type="bibr" rid="CR66">2014</xref>). Therefore, future studies on sexual reward learning in women should preferably include a larger sample of women, in order to investigate the influence of hormonal contraceptives on sexual reward learning. Additionally, in the present study, vaginal photoplethysmography was used as indicator of physiological sexual arousal. Vaginal engorgement, however, is only one of many co-occurring processes during the sexual arousal response. Functional imaging studies on the role of DA in sexual reward learning in healthy men and women may provide complementary insight in neurochemical mechanisms involved in sexual behaviours, which may help foster potentially critical insights in the aetiology of disorders in sexual motivation. Since sexual arousal can eventually result in overt behaviour such as approach and consumption (Dekker and Everaerd <xref ref-type="bibr" rid="CR21">1989</xref>), future studies should also incorporate a behavioural task to assess automatic action tendencies (Brom et al. <xref ref-type="bibr" rid="CR13">2014b</xref>; Wiers et al. <xref ref-type="bibr" rid="CR73">2011</xref>). Lastly, another limitation of the present study is the absence of a between-subjects (unpaired) control group. Such a control group would help to distinguish learning about the CS+ and the CS&#x02212; (Domjan <xref ref-type="bibr" rid="CR26">2010</xref>; Hoffmann et al. <xref ref-type="bibr" rid="CR35">2014</xref>). Therefore, making use of such a control group in future research is desirable.</p><p>In conclusion, the current study is the first that investigated the role of DA in human sexual reward learning. The present results do not indicate an effect of DA antagonism on conditioned sexual response in women. However, effects of inhibiting dopaminergic tone with a DA antagonist (haloperidol) were seen in the magnitude of unconditional genital responding to sexual stimulation. Future studies on the role of DA in human sexual reward learning are warranted, while facilitation as well as impairment of sexual reward learning is relevant in the context of treatment of hyposexual and hypersexual desire disorder.</p></sec></body><back><ack><p>This research was supported by a grant of the Netherlands Organization for Scientific Research (NWO) awarded to Dr. S. Both. The authors wish to thank Elaine Cooman, Yorinn van Voorst, Netteke Koster and Marlou Reijmerink for their assistance in collecting the data.</p></ack><notes notes-type="conflict-interest"><title>Compliance with ethical standards</title><sec id="FPar1"><title>Conflict of interest</title><p>The authors have declared that no competing interests exist.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banasikowski</surname><given-names>TJ</given-names></name><name><surname>Bespalov</surname><given-names>A</given-names></name><name><surname>Drescher</surname><given-names>K</given-names></name><name><surname>Behl</surname><given-names>B</given-names></name><name><surname>Unger</surname><given-names>L</given-names></name><name><surname>Haupt</surname><given-names>A</given-names></name><name><surname>Schoemaker</surname><given-names>H</given-names></name><name><surname>Sullivan</surname><given-names>JP</given-names></name><name><surname>Gross</surname><given-names>G</given-names></name><name><surname>Beninger</surname><given-names>RJ</given-names></name></person-group><article-title>Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats</article-title><source>J Pharmacol Exp Ther</source><year>2010</year><volume>335</volume><fpage>506</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1124/jpet.110.171348</pub-id><pub-id pub-id-type="pmid">20724485</pub-id></element-citation></ref><ref id="CR2"><mixed-citation publication-type="other">Beninger RJ, Phillips AG (1980) The effect of pimozide on the establishment of conditioned reinforcement. Psychopharmacology (Berl) 68:147&#x02013;153</mixed-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>KC</given-names></name></person-group><article-title>The debate over dopamine&#x02019;s role in reward: the case for incentive salience</article-title><source>Psychopharmacology</source><year>2007</year><volume>191</volume><fpage>391</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1007/s00213-006-0578-x</pub-id><pub-id pub-id-type="pmid">17072591</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>KC</given-names></name></person-group><article-title>Food reward: brain substrates of wanting and liking</article-title><source>Neurosci Biobehav Rev</source><year>1996</year><volume>20</volume><fpage>1</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/0149-7634(95)00033-B</pub-id><pub-id pub-id-type="pmid">8622814</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>KC</given-names></name><name><surname>Kringelbach</surname><given-names>ML</given-names></name></person-group><article-title>Affective neuroscience of pleasure: reward in humans and animals</article-title><source>Psychopharmacology (Berl)</source><year>2008</year><volume>199</volume><fpage>457</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1007/s00213-008-1099-6</pub-id><pub-id pub-id-type="pmid">18311558</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>KC</given-names></name><name><surname>Robinson</surname><given-names>TE</given-names></name></person-group><article-title>What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?</article-title><source>Brain Res Rev</source><year>1998</year><volume>28</volume><fpage>309</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/S0165-0173(98)00019-8</pub-id><pub-id pub-id-type="pmid">9858756</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>KC</given-names></name><name><surname>Robinson</surname><given-names>TE</given-names></name></person-group><article-title>Parsing reward</article-title><source>Trends Neurosci</source><year>2003</year><volume>26</volume><fpage>507</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/S0166-2236(03)00233-9</pub-id><pub-id pub-id-type="pmid">12948663</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindra</surname><given-names>D</given-names></name></person-group><article-title>A motivational view of learning. Performance, and behavior modification</article-title><source>Psychol Rev</source><year>1974</year><volume>81</volume><fpage>199</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1037/h0036330</pub-id><pub-id pub-id-type="pmid">4424766</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Both</surname><given-names>S</given-names></name><name><surname>Everaerd</surname><given-names>W</given-names></name><name><surname>Laan</surname><given-names>E</given-names></name><name><surname>Gooren</surname><given-names>L</given-names></name></person-group><article-title>Effect of a single dose of levodopa on sexual response in men and women</article-title><source>Neuropsychopharmacology</source><year>2005</year><volume>30</volume><fpage>173</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1038/sj.npp.1300580</pub-id><pub-id pub-id-type="pmid">15470373</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Both</surname><given-names>S</given-names></name><name><surname>Brauer</surname><given-names>M</given-names></name><name><surname>Laan</surname><given-names>E</given-names></name></person-group><article-title>Classical conditioning of sexual response in women: a replication study</article-title><source>J Sex Med</source><year>2011</year><volume>8</volume><fpage>3116</fpage><lpage>3131</lpage><pub-id pub-id-type="doi">10.1111/j.1743-6109.2011.02453.x</pub-id><pub-id pub-id-type="pmid">21951361</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Both</surname><given-names>S</given-names></name><name><surname>Laan</surname><given-names>E</given-names></name><name><surname>Spiering</surname><given-names>M</given-names></name><name><surname>Nilsson</surname><given-names>T</given-names></name><name><surname>Oomens</surname><given-names>S</given-names></name><name><surname>Everaerd</surname><given-names>W</given-names></name></person-group><article-title>Appetitive and aversive classical conditioning of female sexual response</article-title><source>J Sex Med</source><year>2008</year><volume>5</volume><fpage>1386</fpage><lpage>1401</lpage><pub-id pub-id-type="doi">10.1111/j.1743-6109.2008.00815.x</pub-id><pub-id pub-id-type="pmid">18373525</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brom</surname><given-names>M</given-names></name><name><surname>Both</surname><given-names>S</given-names></name><name><surname>Laan</surname><given-names>E</given-names></name><name><surname>Everaerd</surname><given-names>W</given-names></name><name><surname>Spinhoven</surname><given-names>P</given-names></name></person-group><article-title>The role of conditioning, learning and dopamine in sexual behavior: a narrative review of animal and human studies</article-title><source>Neurosci Biobehav Rev</source><year>2014</year><volume>38</volume><fpage>38</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.10.014</pub-id><pub-id pub-id-type="pmid">24211372</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brom</surname><given-names>M</given-names></name><name><surname>Laan</surname><given-names>E</given-names></name><name><surname>Everaerd</surname><given-names>W</given-names></name><name><surname>Spinhoven</surname><given-names>P</given-names></name><name><surname>Both</surname><given-names>S</given-names></name></person-group><article-title>Extinction and renewal of conditioned sexual responses</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>8</issue><fpage>e105955</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0105955</pub-id><pub-id pub-id-type="pmid">25170909</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brom</surname><given-names>M</given-names></name><name><surname>Laan</surname><given-names>E</given-names></name><name><surname>Everaerd</surname><given-names>W</given-names></name><name><surname>Spinhoven</surname><given-names>P</given-names></name><name><surname>Both</surname><given-names>S</given-names></name></person-group><article-title>Extinction of aversive classically conditioned human sexual response</article-title><source>J Sex Med</source><year>2014</year><volume>12</volume><fpage>916</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1111/jsm.12800</pub-id><pub-id pub-id-type="pmid">25515383</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chivers</surname><given-names>ML</given-names></name><name><surname>Seto</surname><given-names>MC</given-names></name><name><surname>Lalumi&#x000e8;re</surname><given-names>ML</given-names></name><name><surname>Laan</surname><given-names>E</given-names></name><name><surname>Grimbos</surname><given-names>T</given-names></name></person-group><article-title>Agreement of self-reported and genital measures of sexual arousal in men and women: a meta-analysis</article-title><source>Arch Sex Behav</source><year>2010</year><volume>39</volume><fpage>5</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1007/s10508-009-9556-9</pub-id><pub-id pub-id-type="pmid">20049519</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name></person-group><source>Statistical power analysis for the behavioral sciences</source><year>1988</year><edition>2</edition><publisher-loc>New Jersey</publisher-loc><publisher-name>Lawrence Erlbaum</publisher-name></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coria-Avila</surname><given-names>GA</given-names></name><name><surname>Gavrila</surname><given-names>AM</given-names></name><name><surname>Boulard</surname><given-names>B</given-names></name><name><surname>Charron</surname><given-names>N</given-names></name><name><surname>Stanley</surname><given-names>G</given-names></name><name><surname>Pfaus</surname><given-names>JG</given-names></name></person-group><article-title>Neurochemical basis of conditioned partner preference in the female rat: II. Disruption by flupenthixol</article-title><source>Behav Neurosci</source><year>2008</year><volume>122</volume><fpage>396</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1037/0735-7044.122.2.396</pub-id><pub-id pub-id-type="pmid">18410178</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummins</surname><given-names>ED</given-names></name><name><surname>Griffin</surname><given-names>SB</given-names></name><name><surname>Duty</surname><given-names>CM</given-names></name><name><surname>Peterson</surname><given-names>DJ</given-names></name><name><surname>Burgess</surname><given-names>KC</given-names></name><name><surname>Brown</surname><given-names>RW</given-names></name></person-group><article-title>The role of dopamine D1 and D2 receptors in adolescent methylphenidate conditioned place preference: sex differences and brain-derived neurotrophic factor</article-title><source>Dev Neurosci</source><year>2014</year><volume>36</volume><fpage>277</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1159/000360636</pub-id><pub-id pub-id-type="pmid">24821360</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darby</surname><given-names>JK</given-names></name><name><surname>Pasta</surname><given-names>DJ</given-names></name><name><surname>Dabiri</surname><given-names>L</given-names></name><name><surname>Clark</surname><given-names>L</given-names></name><name><surname>Mosbacher</surname><given-names>D</given-names></name></person-group><article-title>Haloperidol dose and blood level variability: toxicity and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting</article-title><source>J Clin Psychopharmacol</source><year>1995</year><volume>15</volume><fpage>334</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1097/00004714-199510000-00005</pub-id><pub-id pub-id-type="pmid">8830064</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jong</surname><given-names>JW</given-names></name><name><surname>Roelofs</surname><given-names>TJM</given-names></name><name><surname>Mol</surname><given-names>FMU</given-names></name><name><surname>Hillen</surname><given-names>AEJ</given-names></name><name><surname>Meijboom</surname><given-names>KE</given-names></name><name><surname>Luijendijk</surname><given-names>MCM</given-names></name><name><surname>Van der Eerden</surname><given-names>HAM</given-names></name><name><surname>Garner</surname><given-names>KM</given-names></name><name><surname>Vanderschuren</surname><given-names>LJMJ</given-names></name><name><surname>Adan</surname><given-names>RAH</given-names></name></person-group><article-title>Reducing ventral tegmental dopamine D2 receptor expression selectively boosts incentive motivation</article-title><source>Neuropsychopharmacology</source><year>2015</year><volume>40</volume><fpage>2085</fpage><lpage>2095</lpage><pub-id pub-id-type="doi">10.1038/npp.2015.60</pub-id><pub-id pub-id-type="pmid">25735756</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Everaerd</surname><given-names>W</given-names></name></person-group><article-title>Psychological determinants of sexual arousal: a review</article-title><source>Behav Res Ther</source><year>1989</year><volume>27</volume><fpage>353</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1016/0005-7967(89)90005-3</pub-id><pub-id pub-id-type="pmid">2673206</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delamater</surname><given-names>AR</given-names></name></person-group><article-title>Experimental extinction in Pavlovian conditioning: behavioural and neuroscience perspectives</article-title><source>Q J Exp Psychol B Comp Physiol Psychol</source><year>2004</year><volume>57</volume><fpage>97</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1080/02724990344000097</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewing</surname><given-names>P</given-names></name><name><surname>Chiang</surname><given-names>CWK</given-names></name><name><surname>Sinchak</surname><given-names>K</given-names></name><name><surname>Sim</surname><given-names>H</given-names></name><name><surname>Fernagut</surname><given-names>PO</given-names></name><name><surname>Kelly</surname><given-names>S</given-names></name><name><surname>Chesselet</surname><given-names>MF</given-names></name><name><surname>Micevych</surname><given-names>PE</given-names></name><name><surname>Albrech</surname><given-names>KH</given-names></name><name><surname>Harley</surname><given-names>VR</given-names></name><name><surname>Vilain</surname><given-names>E</given-names></name></person-group><article-title>Direct regulation of adult brain function by the male-specific factor SRY</article-title><source>Curr Biol</source><year>2006</year><volume>16</volume><fpage>415</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2006.01.017</pub-id><pub-id pub-id-type="pmid">16488877</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Chiara</surname><given-names>G</given-names></name></person-group><article-title>The role of dopamine in drug abuse viewed from the perspective of its role in motivation</article-title><source>Drug Alcohol Depend</source><year>1995</year><volume>38</volume><fpage>95</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/0376-8716(95)01118-I</pub-id><pub-id pub-id-type="pmid">7671769</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname><given-names>JM</given-names></name><name><surname>Hull</surname><given-names>EM</given-names></name></person-group><article-title>Dopamine, the medial preoptic area, and male sexual behavior</article-title><source>Physiol Behav</source><year>2005</year><volume>86</volume><fpage>356</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2005.08.006</pub-id><pub-id pub-id-type="pmid">16135375</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Domjan</surname><given-names>M</given-names></name></person-group><source>The principles of learning and behavior</source><year>2010</year><edition>6</edition><publisher-loc>Belmont</publisher-loc><publisher-name>Wadsworth Cengage Publishing</publisher-name></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlop</surname><given-names>BW</given-names></name><name><surname>Nemeroff</surname><given-names>CB</given-names></name></person-group><article-title>The role of dopamine in the pathophysiology of depression</article-title><source>Arch Gen Psychiatry</source><year>2007</year><volume>64</volume><fpage>327</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.64.3.327</pub-id><pub-id pub-id-type="pmid">17339521</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanselow</surname><given-names>MS</given-names></name><name><surname>Landeira-Fernandez</surname><given-names>J</given-names></name><name><surname>DeCola</surname><given-names>JP</given-names></name><name><surname>Kim</surname><given-names>JJ</given-names></name></person-group><article-title>The immediate shock deficit and postshock analgesia: implications for the relationship between the analgesic CR and UR</article-title><source>Anim Learn Behav</source><year>1994</year><volume>22</volume><fpage>72</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.3758/BF03199957</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fields</surname><given-names>HL</given-names></name><name><surname>Hjelmstad</surname><given-names>GO</given-names></name><name><surname>Margolis</surname><given-names>EB</given-names></name><name><surname>Nicola</surname><given-names>SM</given-names></name></person-group><article-title>Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement</article-title><source>Annu Rev Neurosci</source><year>2007</year><volume>30</volume><fpage>289</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.30.051606.094341</pub-id><pub-id pub-id-type="pmid">17376009</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flagel</surname><given-names>SB</given-names></name><name><surname>Clark</surname><given-names>JJ</given-names></name><name><surname>Robinson</surname><given-names>TE</given-names></name><name><surname>Mayo</surname><given-names>L</given-names></name><name><surname>Czuj</surname><given-names>A</given-names></name><name><surname>Willuhn</surname><given-names>I</given-names></name><etal/></person-group><article-title>A selective role for dopamine in stimulus-reward learning</article-title><source>Nature</source><year>2011</year><volume>469</volume><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nature09588</pub-id><pub-id pub-id-type="pmid">21150898</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flagel</surname><given-names>SB/</given-names></name><name><surname>Robinson</surname><given-names>TE</given-names></name><name><surname>Clark</surname><given-names>JJ</given-names></name><name><surname>Clinton</surname><given-names>SM</given-names></name><name><surname>Watson</surname><given-names>SJ</given-names></name><name><surname>Seeman</surname><given-names>P</given-names></name><etal/></person-group><article-title>An animal model of genetic vulnerability to behavioral disinhibition and responsiveness to reward-related cues: implications for addiction</article-title><source>Neuropsychopharmacology</source><year>2010</year><volume>35</volume><fpage>388</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1038/npp.2009.142</pub-id><pub-id pub-id-type="pmid">19794408</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgiadis</surname><given-names>JR</given-names></name><name><surname>Kringelbach</surname><given-names>ML</given-names></name></person-group><article-title>The human sexual response cycle: brain imaging evidence linking sex to other pleasures</article-title><source>Prog Neurobiol</source><year>2012</year><volume>98</volume><fpage>49</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2012.05.004</pub-id><pub-id pub-id-type="pmid">22609047</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guti&#x000e9;rrez</surname><given-names>G</given-names></name><name><surname>Domjan</surname><given-names>M</given-names></name></person-group><article-title>Differences in the sexual conditioned behavior of male and female Japanese quail (Coturnix japonica)</article-title><source>J Comp Psychol</source><year>1997</year><volume>111</volume><fpage>135</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1037/0735-7036.111.2.135</pub-id><pub-id pub-id-type="pmid">9170278</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermans</surname><given-names>EJ</given-names></name><name><surname>Bos</surname><given-names>PA</given-names></name><name><surname>Ossewaarde</surname><given-names>L</given-names></name><name><surname>Ramsey</surname><given-names>NF</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>G</given-names></name><name><surname>van Honk</surname><given-names>J</given-names></name></person-group><article-title>Effects of exogenous testosterone on the ventral striatal BOLD response during reward anticipation in healthy women</article-title><source>Neuroimage</source><year>2010</year><volume>52</volume><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.04.019</pub-id><pub-id pub-id-type="pmid">20398773</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>H</given-names></name><name><surname>Goodrich</surname><given-names>D</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Janssen</surname><given-names>E</given-names></name></person-group><article-title>The role of classical conditioning in sexual compulsivity: a pilot study</article-title><source>Sex Addict Compulsivity</source><year>2014</year><volume>21</volume><fpage>75</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1080/10720162.2014.895460</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>H</given-names></name><name><surname>Janssen</surname><given-names>E</given-names></name><name><surname>Turner</surname><given-names>SL</given-names></name></person-group><article-title>Classical conditioning of sexual arousal in women and men: effects of varying awareness and biological relevance of the conditioned stimulus</article-title><source>Arch Sex Behav</source><year>2004</year><volume>33</volume><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1023/B:ASEB.0000007461.59019.d3</pub-id><pub-id pub-id-type="pmid">14739689</pub-id></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassubek</surname><given-names>J</given-names></name><name><surname>Abler</surname><given-names>B</given-names></name><name><surname>Pinkhardt</surname><given-names>EH</given-names></name></person-group><article-title>Neural reward processing under dopamine agonists: imaging</article-title><source>J Neurol Sci</source><year>2011</year><volume>310</volume><fpage>36</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2011.06.043</pub-id><pub-id pub-id-type="pmid">21762926</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klucken</surname><given-names>T</given-names></name><name><surname>Schweckendiek</surname><given-names>J</given-names></name><name><surname>Christian</surname><given-names>J</given-names></name><name><surname>Merz</surname><given-names>CJ</given-names></name><name><surname>Tabbert</surname><given-names>K</given-names></name><name><surname>Walter</surname><given-names>B</given-names></name><name><surname>Kagerer</surname><given-names>S</given-names></name><name><surname>Vaitl</surname><given-names>D</given-names></name><name><surname>Stark</surname><given-names>R</given-names></name></person-group><article-title>Neural activations of the acquisition of conditioned sexual arousal: effects of contingency awareness and sex</article-title><source>J Sex Med</source><year>2009</year><volume>6</volume><fpage>3071</fpage><lpage>3085</lpage><pub-id pub-id-type="doi">10.1111/j.1743-6109.2009.01405.x</pub-id><pub-id pub-id-type="pmid">19656273</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kringelbach</surname><given-names>ML</given-names></name><name><surname>Berridge</surname><given-names>KC</given-names></name></person-group><article-title>Towards a functional neuroanatomy of pleasure and happiness</article-title><source>Trends Cogn Sci</source><year>2009</year><volume>13</volume><fpage>479</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1016/j.tics.2009.08.006</pub-id><pub-id pub-id-type="pmid">19782634</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laan</surname><given-names>E</given-names></name><name><surname>Both</surname><given-names>S</given-names></name></person-group><article-title>What makes women experience desire?</article-title><source>Fem Psychol</source><year>2008</year><volume>18</volume><fpage>505</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1177/0959353508095533</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laan</surname><given-names>E</given-names></name><name><surname>Everaerd</surname><given-names>W</given-names></name></person-group><article-title>Determinants of female sexual arousal: psychophysiological theory and data</article-title><source>Annu Rev Sex Res</source><year>1995</year><volume>6</volume><fpage>32</fpage><lpage>76</lpage></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laan</surname><given-names>E</given-names></name><name><surname>Everaerd</surname><given-names>W</given-names></name><name><surname>Evers</surname><given-names>A</given-names></name></person-group><article-title>Assessment of female sexual arousal: response specificity and construct validity</article-title><source>Psychophysiology</source><year>1995</year><volume>32</volume><fpage>476</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1111/j.1469-8986.1995.tb02099.x</pub-id><pub-id pub-id-type="pmid">7568642</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liem-Moolenaar</surname><given-names>M</given-names></name><name><surname>Gray</surname><given-names>FA</given-names></name><name><surname>de Visser</surname><given-names>SJ</given-names></name><name><surname>Franson</surname><given-names>KL</given-names></name><name><surname>Schoemaker</surname><given-names>RC</given-names></name><name><surname>Schmitt</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol</article-title><source>J Psychopharmacol</source><year>2010</year><volume>24</volume><fpage>73</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1177/0269881108094524</pub-id><pub-id pub-id-type="pmid">18755817</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombardo</surname><given-names>MV</given-names></name><name><surname>Ashwin</surname><given-names>E</given-names></name><name><surname>Auyeung</surname><given-names>B</given-names></name><name><surname>Chakrabarti</surname><given-names>B</given-names></name><name><surname>Lai</surname><given-names>M-C</given-names></name><name><surname>Taylor</surname><given-names>K</given-names></name><name><surname>Hackett</surname><given-names>G</given-names></name><name><surname>Bullmore</surname><given-names>ET</given-names></name><name><surname>Baron-Cohen</surname><given-names>S</given-names></name></person-group><article-title>Fetal programming effects of testosterone on the reward system and behavioral approach tendencies in humans</article-title><source>Biol Psychiatry</source><year>2012</year><volume>72</volume><fpage>839</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2012.05.027</pub-id><pub-id pub-id-type="pmid">22763187</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez</surname><given-names>HH</given-names></name><name><surname>Ettenberg</surname><given-names>A</given-names></name></person-group><article-title>Sexually conditioned incentives: attenuation of motivational impact during dopamine receptor antagonism</article-title><source>Pharmacol Biochem Behav</source><year>2002</year><volume>72</volume><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/S0091-3057(01)00732-8</pub-id><pub-id pub-id-type="pmid">11900770</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milad</surname><given-names>MR</given-names></name><name><surname>Goldstein</surname><given-names>JM</given-names></name><name><surname>Orr</surname><given-names>SP</given-names></name><name><surname>Wedig</surname><given-names>MM</given-names></name><name><surname>Klibanski</surname><given-names>A</given-names></name><name><surname>Pitman</surname><given-names>RK</given-names></name><etal/></person-group><article-title>Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans</article-title><source>Behav Neurosci</source><year>2006</year><volume>120</volume><fpage>1196</fpage><lpage>1203</lpage><pub-id pub-id-type="doi">10.1037/0735-7044.120.5.1196</pub-id><pub-id pub-id-type="pmid">17201462</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordstrom</surname><given-names>AL</given-names></name><name><surname>Farde</surname><given-names>L</given-names></name><name><surname>Halldin</surname><given-names>C</given-names></name></person-group><article-title>Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol</article-title><source>Psychopharmacology (Berl)</source><year>1992</year><volume>106</volume><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1007/BF02244811</pub-id><pub-id pub-id-type="pmid">1533719</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Donohue</surname><given-names>WT</given-names></name><name><surname>Plaud</surname><given-names>JJ</given-names></name></person-group><article-title>The conditioning of human sexual arousal</article-title><source>Arch Sex Behav</source><year>1994</year><volume>23</volume><fpage>321</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1007/BF01541567</pub-id><pub-id pub-id-type="pmid">8024444</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oei</surname><given-names>N</given-names></name><name><surname>Rombouts</surname><given-names>S</given-names></name><name><surname>Soeter</surname><given-names>R</given-names></name><name><surname>Gerven</surname><given-names>J</given-names></name><name><surname>Both</surname><given-names>S</given-names></name></person-group><article-title>Dopamine modulates reward system activity during subconscious processing of sexual stimuli</article-title><source>Neuropsychopharmacology</source><year>2012</year><volume>37</volume><fpage>1729</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.1038/npp.2012.19</pub-id><pub-id pub-id-type="pmid">22395731</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pessiglione</surname><given-names>M</given-names></name><name><surname>Seymour</surname><given-names>B</given-names></name><name><surname>Flandin</surname><given-names>G</given-names></name><name><surname>Dolan</surname><given-names>RJ</given-names></name><name><surname>Frith</surname><given-names>CD</given-names></name></person-group><article-title>Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans</article-title><source>Nature</source><year>2006</year><volume>442</volume><fpage>1042</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1038/nature05051</pub-id><pub-id pub-id-type="pmid">16929307</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaus</surname><given-names>JG</given-names></name><name><surname>Kippin</surname><given-names>TE</given-names></name><name><surname>Centeno</surname><given-names>S</given-names></name></person-group><article-title>Conditioning and sexual behavior: a review</article-title><source>Horm Behav</source><year>2001</year><volume>40</volume><fpage>291</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1006/hbeh.2001.1686</pub-id><pub-id pub-id-type="pmid">11534994</pub-id></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>RC</given-names></name><name><surname>Kumaresan</surname><given-names>V</given-names></name></person-group><article-title>The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?</article-title><source>Neurosci Biobehav Rev</source><year>2006</year><volume>30</volume><fpage>216</fpage><lpage>238</lpage></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzagalli</surname><given-names>DA</given-names></name><name><surname>Evins</surname><given-names>AE</given-names></name><name><surname>Schetter</surname><given-names>E</given-names></name><name><surname>Frank</surname><given-names>MJ</given-names></name><name><surname>Pajtas</surname><given-names>PE</given-names></name><name><surname>Santesso</surname><given-names>DL</given-names></name><name><surname>Culhune</surname><given-names>M</given-names></name></person-group><article-title>Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness</article-title><source>Psychopharmacology (Berl)</source><year>2008</year><volume>196</volume><fpage>221</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1007/s00213-007-0957-y</pub-id><pub-id pub-id-type="pmid">17909750</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pleger</surname><given-names>B</given-names></name><name><surname>Ruff</surname><given-names>CC</given-names></name><name><surname>Blankenburg</surname><given-names>F</given-names></name><name><surname>Kloppel</surname><given-names>S</given-names></name><name><surname>Driver</surname><given-names>J</given-names></name><name><surname>Dolan</surname><given-names>RJ</given-names></name></person-group><article-title>Influence of dopaminergically mediated reward on somatosensory decision-making</article-title><source>PLoS Biol</source><year>2009</year><volume>7</volume><fpage>e1000164</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.1000164</pub-id><pub-id pub-id-type="pmid">19636360</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pletzer</surname><given-names>BA</given-names></name><name><surname>Kerschbaum</surname><given-names>HH</given-names></name></person-group><article-title>50 years of hormonal contraception&#x02014;time to find out, what it does to our brain</article-title><source>Front Neurosci</source><year>2014</year><volume>8</volume><fpage>256</fpage><pub-id pub-id-type="pmid">25191220</pub-id></element-citation></ref><ref id="CR56"><mixed-citation publication-type="other">Ranaldi R, Beninger RJ (1993) Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats. Psychopharmacology 113:110&#x02013;118</mixed-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riba</surname><given-names>J</given-names></name><name><surname>Kr&#x000e4;mer</surname><given-names>UM</given-names></name><name><surname>Heldmann</surname><given-names>M</given-names></name><name><surname>Richter</surname><given-names>S</given-names></name><name><surname>M&#x000fc;nte</surname><given-names>TF</given-names></name></person-group><article-title>Dopamine agonist increases risk taking but blunts reward-related brain activity</article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><fpage>e2479</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0002479</pub-id><pub-id pub-id-type="pmid">18575579</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>JM</given-names></name><name><surname>Castro</surname><given-names>DC</given-names></name><name><surname>DiFeliceantonio</surname><given-names>AG</given-names></name><name><surname>Robinson</surname><given-names>MJF</given-names></name><name><surname>Berridge</surname><given-names>KC</given-names></name></person-group><article-title>Mapping brain circuits of reward and motivation: in the footsteps of Ann Kelley</article-title><source>Neurosci Biobehav Rev</source><year>2013</year><volume>37</volume><fpage>1919</fpage><lpage>1931</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.12.008</pub-id><pub-id pub-id-type="pmid">23261404</pub-id></element-citation></ref><ref id="CR59"><mixed-citation publication-type="other">Root DH, Melendez RI, Zaborszky L, Napier TC (2015) The ventral pallidum: subregion-specific functional anatomy and roles in motivated behaviors. Progress in Neurobiology, in press.</mixed-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Heiman</surname><given-names>J</given-names></name><name><surname>Leiblum</surname><given-names>S</given-names></name><name><surname>Meston</surname><given-names>C</given-names></name><etal/></person-group><article-title>The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function</article-title><source>J Sex Marital Ther</source><year>2000</year><volume>26</volume><fpage>191</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1080/009262300278597</pub-id><pub-id pub-id-type="pmid">10782451</pub-id></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santesso</surname><given-names>DL</given-names></name><name><surname>Bogdan</surname><given-names>R</given-names></name><name><surname>Birk</surname><given-names>JL</given-names></name><name><surname>Goetz</surname><given-names>EL</given-names></name><name><surname>Holmes</surname><given-names>AJ</given-names></name><name><surname>Pizzagalli</surname><given-names>DA</given-names></name></person-group><article-title>Neural responses to negative feedback are related to negative emotionality in healthy adults</article-title><source>Soc Cogn Affect Neurosci</source><year>2011</year><volume>7</volume><fpage>794</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1093/scan/nsr054</pub-id><pub-id pub-id-type="pmid">21917847</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname><given-names>W</given-names></name></person-group><article-title>Getting formal with dopamine and reward</article-title><source>Neuron</source><year>2002</year><volume>36</volume><fpage>241</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(02)00967-4</pub-id><pub-id pub-id-type="pmid">12383780</pub-id></element-citation></ref><ref id="CR63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>DV</given-names></name><name><surname>Lecrubier</surname><given-names>Y</given-names></name><name><surname>Sheehan</surname><given-names>KH</given-names></name><name><surname>Amorim</surname><given-names>P</given-names></name><name><surname>Janavs</surname><given-names>J</given-names></name><name><surname>Weiller</surname><given-names>E</given-names></name><name><surname>Herqueta</surname><given-names>T</given-names></name><name><surname>Baker</surname><given-names>R</given-names></name><name><surname>Dunbar</surname><given-names>GC</given-names></name></person-group><article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title><source>J Clin Psychiatry</source><year>1998</year><volume>59</volume><fpage>22</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">9881538</pub-id></element-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeman</surname><given-names>P</given-names></name></person-group><article-title>Atypical antipsychotics: mechanism of action</article-title><source>Can J Psychiatr</source><year>2002</year><volume>47</volume><fpage>27</fpage><lpage>38</lpage></element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>B</given-names></name><name><surname>Toates</surname><given-names>FM</given-names></name></person-group><article-title>Sexual motivation</article-title><source>J Sex Res</source><year>1987</year><volume>23</volume><fpage>481</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1080/00224498709551386</pub-id></element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotomayor-Zarate</surname><given-names>R</given-names></name><name><surname>Cruz</surname><given-names>G</given-names></name><name><surname>Renard</surname><given-names>GM</given-names></name><name><surname>Espinosa</surname><given-names>P</given-names></name><name><surname>Ramirez</surname><given-names>VD</given-names></name></person-group><article-title>Sex hormones and brain dopamine functions</article-title><source>Cent Nerv Syst Agents Med Chem</source><year>2014</year><volume>14</volume><fpage>62</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.2174/1871524914666141226105137</pub-id><pub-id pub-id-type="pmid">25540983</pub-id></element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suschinsky</surname><given-names>K</given-names></name><name><surname>Lalumi&#x000e8;re</surname><given-names>ML</given-names></name><name><surname>Chivers</surname><given-names>ML</given-names></name></person-group><article-title>Sex differences in patterns of genital arousal: measurement artifact or true phenomenon?</article-title><source>Arch Sex Behav</source><year>2009</year><volume>38</volume><fpage>559</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1007/s10508-008-9339-8</pub-id><pub-id pub-id-type="pmid">18343987</pub-id></element-citation></ref><ref id="CR68"><mixed-citation publication-type="other">Taylor JR, Robbins TW (1984) Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens.&#x000a0;Psychopharmacology (Berl) 84:405&#x02013;412</mixed-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ter Kuile</surname><given-names>MM</given-names></name><name><surname>Brauer</surname><given-names>M</given-names></name><name><surname>Laan</surname><given-names>E</given-names></name></person-group><article-title>The Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS): psychometric properties within a Dutch population</article-title><source>J Sex Marital Ther</source><year>2006</year><volume>32</volume><fpage>289</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1080/00926230600666261</pub-id><pub-id pub-id-type="pmid">16709550</pub-id></element-citation></ref><ref id="CR70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toates</surname><given-names>F</given-names></name></person-group><article-title>An integrative theoretical framework for understanding sexual motivation, arousal, and behavior</article-title><source>J Sex Res</source><year>2009</year><volume>46</volume><fpage>168</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1080/00224490902747768</pub-id><pub-id pub-id-type="pmid">19308842</pub-id></element-citation></ref><ref id="CR71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Videbaeck</surname><given-names>C</given-names></name><name><surname>Toska</surname><given-names>K</given-names></name><name><surname>Friberg</surname><given-names>L</given-names></name><name><surname>Holm</surname><given-names>S</given-names></name><name><surname>Angelo</surname><given-names>HR</given-names></name><name><surname>Knudsen</surname><given-names>GM</given-names></name></person-group><article-title>In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography</article-title><source>J Cereb Blood Flow Metab</source><year>2001</year><volume>21</volume><fpage>92</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1097/00004647-200101000-00012</pub-id><pub-id pub-id-type="pmid">11149673</pub-id></element-citation></ref><ref id="CR72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wise</surname><given-names>RA</given-names></name></person-group><article-title>Brain reward circuitry: insights from unsensed incentives</article-title><source>Neuron</source><year>2002</year><volume>36</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(02)00965-0</pub-id><pub-id pub-id-type="pmid">12383779</pub-id></element-citation></ref><ref id="CR73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiers</surname><given-names>RW</given-names></name><name><surname>Eberl</surname><given-names>C</given-names></name><name><surname>Rinck</surname><given-names>M</given-names></name><name><surname>Becker</surname><given-names>ES</given-names></name><name><surname>Lindenmeyer</surname><given-names>J</given-names></name></person-group><article-title>Retraining automatic action tendencies changes alcoholic patients&#x02019; approach bias for alcohol and improves treatment outcome</article-title><source>Psychol Sci</source><year>2011</year><volume>22</volume><fpage>490</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1177/0956797611400615</pub-id><pub-id pub-id-type="pmid">21389338</pub-id></element-citation></ref><ref id="CR74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolterink</surname><given-names>G</given-names></name><name><surname>Phillips</surname><given-names>G</given-names></name><name><surname>Cador</surname><given-names>M</given-names></name><name><surname>Donelaar-Wolterink</surname><given-names>I</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name><name><surname>Everitt</surname><given-names>BJ</given-names></name></person-group><article-title>Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement</article-title><source>Psychopharmacology</source><year>1993</year><volume>110</volume><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1007/BF02251293</pub-id><pub-id pub-id-type="pmid">7831431</pub-id></element-citation></ref><ref id="CR75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>RI</given-names></name></person-group><article-title>Anabolic&#x02013;androgenic steroid dependence? Insights from animals and humans</article-title><source>Front Neuroendocrinol</source><year>2008</year><volume>29</volume><fpage>490</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/j.yfrne.2007.12.002</pub-id><pub-id pub-id-type="pmid">18275992</pub-id></element-citation></ref><ref id="CR76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zweifel</surname><given-names>LS</given-names></name><name><surname>Fadok</surname><given-names>JP</given-names></name><name><surname>Argilli</surname><given-names>E</given-names></name><name><surname>Garelick</surname><given-names>MG</given-names></name><name><surname>Jones</surname><given-names>GL</given-names></name><name><surname>Dickerson</surname><given-names>TMK</given-names></name><name><surname>Allen</surname><given-names>JM</given-names></name><name><surname>Mizumori</surname><given-names>MG</given-names></name><name><surname>Bonci</surname><given-names>A</given-names></name><name><surname>Palmiter</surname><given-names>RD</given-names></name></person-group><article-title>Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety</article-title><source>Nat Neurosci</source><year>2011</year><volume>14</volume><fpage>620</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1038/nn.2808</pub-id><pub-id pub-id-type="pmid">21499253</pub-id></element-citation></ref></ref-list></back></article>